Meeting report

EPCCS 2014

Report of 7th Annual EPCCS meeting held in Brussels.


7th Annual Scientific Meeting Cardiovascular Disease 2014

 

Clinical Master Class
September 18–19, 2014 Brussels, Belgium

 


General Practitioners from different corners in Europe gathered in Brussels for the 7th EPCCS Annual meeting, to discuss the latest developments in cardiovascular medicine, with a focus on primary care. The EPCCS scientific sessions started with a plenary debate on controversies on treating CVD risk: is treating 10-year risk the best, or rather lifetime risk, or should we use a polypill at the age of 55 years?
Dr. Thierry Christiaens (Ghent, Belgium) made the case for continuing to treat 10-year risk. He noted that it has not been proven as yet that using a risk scoring tool gives more CV protection than usual care. He stated that it may not be so important to know the exact risk, but more to know when to start treating. Validating new scores and incorporating them into software and brain takes a long time, which might be better used.
Dr. Arno Hoes (Utrecht, The Netherlands) then advocated to use lifetime risk, because some patients, like young women, have a low short-term risk, while they have a high risk, if they have multiple risk factors, when lifetime risk is considered.  
Dr. Carlos Brotons (Barcelona, Spain) showed evidence for use of a polypill, which, to date, remains limited. Effects on mortality or CVD events are uncertain, possibly because studies were not powered to detect these effects. Adherence to treatment seems somewhat improved with a polypill, and, especially in developing countries, healthcare costs may be reduced as a consequence of better adherence and prevention. Hard endpoint trials with polypills are underway. Future studies will need to demonstrate whether polypills can play a role as an integral part of comprehensive CVD prevention.
A debate between the speakers and the audience followed, after which almost everybody considered lifetime risk the best tool to use.
 
The next session was a Clinical Updates on Vascular Disease Master Class.

Follow the link below for more information and resources of this EPCCS master class.

EPCCS Master Class : CLINICAL UPDATES ON VASCULAR DISEASE

 


After lunch it was time for a Master Class on Clinical Updates on Diabetes, Hypertension and SPAF.

Follow the link below for more information and resources of this EPCCS master class.

EPCCS Master Class : CLINICAL UPDATES ON DIABETES, HYPERTENSION AND SPAF

 
In the last session of the first day of the meeting, EPCCS members had the chance to present their research. Janneke Hendriksen (The Netherlands) works on diagnostic prediction models for suspected pulmonary embolism in primary care and showed results of an independent external validation study, which showed that PE can safely be excluded in primary care by means of a negative D-dimer test and using the original and simplified Wells rules. Dr. Wim Lucassen (The Netherlands) considered the advantages of a Quantitative D-dimer test or a point of care (POC) qualitative test in excluding pulmonary embolism (PE). This simplified test can give results within 10 minutes. Andrew Murphy (Ireland) presented data of the six year follow-up of the SPHERE cluster trial and showed the effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice, plus a systematic review. He concludes that it is important that we need to continue to keep doing the simple things well. Gunnar Nilsson (Sweden) spoke about the use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study in Swedish primary care. A referral bias was observed such that from the patients with a positive exercise test, referral rates to cardiological care decreased with age. Steven Uittenbogaart (The Netherlands) announced the D2AF study and explained the rationale of this study on detection and diagnosing atrial fibrillation, that aims to determine the extra yield of opportunistic case-finding. Antigoni Volikou (Greece) ended this session by discussing a the first Greek guideline for the management of dyslipidaemia in Greek primary health care. The next step is to seek approval of the Ministry of Health.
 
The second day of the EPCCS programme started with a plenary master class with rapid clinical updates.

Follow the link below for more information and resources of this EPCCS master class.

EPCCS Master Class : RAPID CLINICAL UPDATES

 
The next plenary master class focussed on Emerging Priorities in CVD.

Follow the link below for more information and resources of this EPCCS master class.

EPCCS Master Class : MASTERCLASS ON EMERGING PRIORITIES IN CVD

 
In the last masterclass, lifestyle changes were discussed.
Follow the link below for more information and resources of this EPCCS master class.

EPCCS Master Class : MASTERCLASS ON LIFESTYLE CHANGE

 
In the last session of the meeting, it was announced that the audience had voted that Steven Uittenbogaart should win the best oral abstract presenter award. The best poster award was given to Per. O. Andersen.
Prof. Christos Lionis and dr. Monika Hollander then ended the meeting with an interactive session in which various case studies were discussed, in which many clinical dilemma’s were considered. Update • 16-10-2014 Update • 16-10-2014

 

-- Follow the links to the individual master class pages for more information on what was discussed, the presentations and videos with the speakers --


Arno HoesCarlos BrotonsChristos LionisDavid Fitzmauriceepccs 2014Frans RuttenGeert-Jan GeersingIan CampbellMonika HollanderRichard HobbsRichard McManusThierry ChristiaensXavier Borras

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...